TPG GP A, LLC

Holdings History for Allogene Therapeutics, Inc. - Common Stock (ALLO)

Symbol: ALLO on Nasdaq
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Price	All Holders
31 Dec 2025	0.95%	0%	$25,641,339	18,716,306	$1.37	Q4 2025
30 Sep 2025	1.3%	0%	$23,208,219	18,716,306	$1.24	Q3 2025
30 Jun 2025	1.1%	0%	$21,149,426	18,716,306	$1.13	Q2 2025
31 Mar 2025	0.55%	0%	$27,325,807	18,716,306	$1.46	Q1 2025
31 Dec 2024	0.64%	0%	$39,865,732	18,716,306	$2.13	Q4 2024
30 Sep 2024	0.89%	0%	$52,405,657	18,716,306	$2.80	Q3 2024
30 Jun 2024	0.68%	0%	$43,608,993	18,716,306	$2.33	Q2 2024
31 Mar 2024	1.6%	0%	$83,661,888	18,716,306	$4.47	Q1 2024
31 Dec 2023	0.97%	0%	$60,079,342	18,716,306	$3.21	Q4 2023
30 Sep 2023	1%	0%	$59,330,690	18,716,306	$3.17	Q3 2023
30 Jun 2023	1.4%	0%	$93,020,041	18,716,306	$4.97	Q2 2023
31 Mar 2023	1.5%	0%	$92,458,552	18,716,306	$4.94	Q1 2023
31 Dec 2022	2.3%	0%	$117,725,565	18,716,306	$6.29	Q4 2022
30 Sep 2022	3.3%	0%	$202,136,000	18,716,306	$10.80	Q3 2022
30 Jun 2022	3.3%	0%	$213,366,000	18,716,306	$11.40	Q2 2022
31 Mar 2022	2.1%	0%	$170,506,000	18,716,306	$9.11	Q1 2022
31 Dec 2021	2.8%	0%	$279,247,000	18,716,306	$14.92	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.